Biolex Therapeutics, Inc. — Form D
Biolex Therapeutics, Inc. of PITTSBORO, NC, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-09. The offering totals $6.7M, of which $5.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-06-09
- Form: D
- Accession: 0001407698-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.7M
- Amount sold: $5.9M
- Remaining: $775K
- Investors: 13
- Date of first sale: 2011-05-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-161034
Issuer
- Name: Biolex Therapeutics, Inc.
- CIK: 0001407698
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 158 CREDLE STREET, PITTSBORO, NC, 27312
- Phone: (919) 542-9901
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Kevin A Bitterman | Director | Pittsboro, NC |
| Klaus Thomas Veitinger | Director | New York, NY |
| P. Sherrill Neff | Director | Wayne, PA |
| Dale A Sander | Executive Officer | Valencia, CA |
| Dennis J Dougherty | Director | Raleigh, NC |
| David P Spencer | Executive Officer | Pittsboro, NC |
| Jan P Turek | Director | Pittsboro, NC |
| Jan P Turek | Executive Officer | Pittsboro, NC |
| Kurt Page Graves | Director | Pittsboro, NC |
| Kurt Page Graves | Executive Officer | Pittsboro, NC |
| David L Castaldi | Director | Chestnut Hill, MA |
| Jeffrey Thomas Leiden | Director | Cambridge, MA |
| W. Thomas Amick | Director | Emerald Isle, NC |
| Liza Page Nelson | Director | New York, NY |
| Liza Sherrill Page Nelson | Director | New York, NY |
| David Sherrill Castaldi | Director | Chestnut Hill, MA |
| Jeff Thomas Leiden | Director | Cambridge, MA |
| Glen A Williams | Executive Officer | Pittsboro, NC |
Other filings by this issuer (3)
More